Dentists in Ulysses, KS Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Jake Teichert Garn, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 209 W Central Ave, Ulysses, KS 67880 Phone: 620-424-4311 |
Kenneth E Bean Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 113 S Main St, Ulysses, KS 67880 Phone: 620-424-4499 |
Dr. Theodore Joseph Maple, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 307 N Main St, Ulysses, KS 67880 Phone: 620-356-1221 Fax: 620-356-5204 |
Bradyn Matthew Bishop, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 209 W Central Ave, Ulysses, KS 67880 Phone: 801-879-8381 |
Dr. John Robert Cozzens, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 209 W Central Ave, Ulysses, KS 67880 Phone: 620-424-4311 |
News Archive
Hypoplastic left heart syndrome likely caused by genetic factors
Hypoplastic Left Heart Syndrome (HLHS), a severe cardiovascular malformation that is difficult to treat and often lethal, is caused primarily by genetic factors, according to a new study by researchers at Cincinnati Children's Hospital Medical Center.
Uptake Medical completes Series B financing led by Maverick Capital
Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.
Launch of one of the US's largest electronic medical record implementations
As part of an ongoing mission to improve the quality and safety of patient care, Buffalo Hospital is the first Allina hospital to transition away from paper processes and begin using an electronic medical record system that will ultimately be shared by all of Allina's seventy-six sites, including 11 hospitals and sixty-five clinics.
Advaxis CEO issues statement to shareholders regarding recent common stock transition
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
Researchers synthesize new polysulfide donor that has high anti-inflammatory effect
Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.
› Verified 3 days ago